Core Viewpoint - A class action lawsuit has been filed against Inspire Medical Systems, Inc. for misrepresentations regarding the market demand and launch of its sleep apnea device, Inspire V, during the specified Class Period [2][6]. Group 1: Lawsuit Details - The class action lawsuit is on behalf of purchasers of Inspire Medical common stock between August 6, 2024, and August 4, 2025 [2]. - Defendants allegedly made materially false and misleading statements about the demand for Inspire V and the company's readiness for its launch, leading to investor damages when the truth was revealed [6]. Group 2: Investor Information - Investors who purchased Inspire Medical common stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - To participate in the class action, investors must act before the deadline of January 5, 2026, to serve as lead plaintiff [4]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including over $438 million for investors in 2019 [5]. - The firm has been recognized for its success in securities class action settlements, ranking No. 1 in 2017 and consistently in the top 4 since 2013 [5].
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP